November 28, 2015
Recommended Topic Related To:


"The US Food and Drug Administration (FDA) today approved asfotase alfa (Strensiq, Alexion Pharmaceuticals) as the first-ever therapy for patients who develop hypophosphatasia, a rare metabolic bone disorder, in childhood.



Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

How Supplied


Wigraine (ergotamine and caffeine) ® (ergotamine tartrate and caffeine tablets, USP) is indicated as therapy to abort or prevent vascular headaches such as migraine, migraine variants, or so-called histamine cephalalgia.



Best results are obtained if the tablets are administered at the first sign of an attack.

The average adult dose is 2 tablets at the start of a vascular headache (migraine) attack; followed by 1 additional tablet every 1 / 2 hour if needed, up to 6 tablets per attack. Total weekly dosage should not exceed 10 tablets.



Wigraine (ergotamine and caffeine) ® tablets are white tablets embossed with "ORGANON 542" on one side. They are individually foil stripped and packaged in boxes of 20's NDC #0052-0542-20 and 100's NDC #0052-0542-91.


Wigraine (ergotamine and caffeine) ® tablets should be stored at a maximum of 30°C (86°F).


Rx only

Organon Inc.
West Orange, NJ 07052

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 12/8/2004

How Supplied

Wigraine - User Reviews

Wigraine User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Wigraine sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Living Better

Find the secrets to longer life.